ArticleTrials2022
DUDE - a universal prevention program for non-suicidal self-injurious behavior in adolescence based on effective emotion regulation: study protocol of a cluster-randomized controlled trial.
Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Risk Factors Addressed in Programs for the Prevention of Child and Adolescent Suicide in the School Setting: A Systematic Review.Actas espanolas de psiquiatria · 2025Pooled it
- Prevention of self-harm and suicide in young people up to the age of 25 in education settings.The Cochrane database of systematic reviews · 2024Pooled it
- Effects of a Whole-School Prevention Program Targeting Mental Health and Nonsuicidal Self-Injury in Swedish Adolescents: A Cluster-Randomized Experimental Study with Longitudinal Follow-Up.Journal of youth and adolescence · 2026Trial
- Childhood maltreatment and non-suicidal self-injury in college students:Frontiers in psychology · 2026Article
- The role of difficulties in emotion regulation on non-suicidal self-injury and suicide attempts: a cross-sectional study of Chinese adolescents.Scientific reports · 2025Article
- "Thrown in the deep end": a qualitative study of barriers secondary school staff encounter when addressing self-harm.BMC public health · 2025Article
- Prevalence and correlates of nonsuicidal self-injury among youths in Singapore: findings from the National Youth Mental Health Study.Child and adolescent psychiatry and mental health · 2025Article
- Association between Life's Essential 8 and depression: a population-based study.Archives of medical science : AMS · 2025Article
- Emotional dysregulation and its pathways to suicidality in a community-based sample of adolescents.Child and adolescent psychiatry and mental health · 2024Article
- Scoping review on socioemotional skills in the prevention of suicidal behavior among adolescents.Cadernos de saude publica · 2024Article
- Psychopathology, Protective Factors, and COVID-19 among Adolescents: A Structural Equation Model.International journal of environmental research and public health · 2023Article
- Universal prevention for non-suicidal self-injury in adolescents is scarce - A systematic review.Frontiers in psychiatry · 2023Review
- Mental disorders at the beginning of adolescence: Prevalence estimates in a sample aged 11-14 years.Public health in practice (Oxford, England) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-suicidal self-injury (NSSI) has become a substantial public health problem. NSSI is a high-risk marker for the development and persistence of mental health problems, shows high rates of morbidity and mortality, and causes substantial health care costs. Thus, there is an urgent need for action to develop universal prevention programs for NSSI before adolescents begin to show this dangerous behavior. Currently, however, universal prevention programs are lacking.
methodsThe main objective of the present study is to evaluate a newly developed universal prevention program ("DUDE - Du und deine Emotionen / You and your emotions"), based on a skills-based approach in schools, in 3200 young adolescents (age 11-14 years). The effectiveness of DUDE will be investigated in a cluster-randomized controlled trial (RCT) in schools (N = 16). All groups will receive a minimal intervention called "Stress-free through the school day" as a mental health literacy program to prevent burnout in school. The treatment group (N = 1600; 8 schools) will additionally undergo the universal prevention program DUDE and will be divided into treatment group 1 (DUDE conducted by trained clinical psychologists; N = 800; 4 schools) and treatment group 2 (DUDE conducted by trained teachers; N = 800; 4 schools). The active control group (N = 1600; 8 schools) will only receive the mental health literacy prevention. Besides baseline assessment (T0), measurements will occur at the end of the treatment (T1) and at 6- (T2) and 12-month (T3) follow-up evaluations. The main outcome is the occurrence of NSSI within the last 6 months assessed by a short version of the Deliberate Self-Harm Inventory (DSHI-9) at the 1-year follow-up (primary endpoint; T3). Secondary outcomes are emotion regulation, suicidality, health-related quality of life, self-esteem, and comorbid psychopathology and willingness to change. DISCUSSION: DUDE is tailored to diminish the incidence of NSSI and to prevent its possible long-term consequences (e.g., suicidality) in adolescents. It is easy to access in the school environment. Furthermore, DUDE is a comprehensive approach to improve mental health via improved emotion regulation.
trial registrationGerman Clinical Trials Register (DRKS) DRKS00018945. Registered on 01 April 2020, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00018945.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.